Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.72 USD
Change Today 0.00 / 0.00%
Volume 107.4K
NEO On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitleKey Developments
Michael Dent M.D. 6 RelationshipsFounder, Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance CommitteeNeogenomics Inc. announced delayed 10-Q filing
11/16/09
Raymond Hipp 15 RelationshipsIndependent Director and Chairman of Audit CommitteeNeogenomics Inc. announced delayed annual 10-K filing
03/31/09
Kevin Johnson 17 RelationshipsIndependent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance CommitteeNeogenomics Inc. Restates Earnings Results for the Year Ended December 31, 2007
04/15/08
Bruce Crowther 6 RelationshipsDirector, Member of Audit Committee and Member of Compliance Committee 

Compensation Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitle
Michael Dent M.D. 6 RelationshipsFounder, Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance Committee
Kevin Johnson 17 RelationshipsIndependent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance Committee
William Robison 24 RelationshipsIndependent Director and Chairman of Compensation Committee
NEO Compensation vs. Industry
425.0K
346.4K
Chief Executive Officer
245.5K
304.8K
Chief Financial Officer
Share price activity for NEOGENOMICS INC (NEO)
52 Week Price Performance
NEO
Industry Average
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $4.72 USD 0.00

NEO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $2.88 USD -0.12
Psychemedics Corp $16.30 USD +0.02
Response Genetics Inc $0.45 USD -0.0065
Rosetta Genomics Ltd $2.98 USD -0.075
Signal Genetics Inc $2.36 USD -0.03
View Industry Companies
 

Industry Analysis

NEO

Industry Average

Valuation NEO Industry Range
Price/Earnings 100.0x
Price/Sales 3.3x
Price/Book 4.7x
Price/Cash Flow 251.2x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.